Serhat TUNAR -TDO- Oxford University has announced it has completed phase one of clinical trials with UK-based pharmaceutical firm AstraZeneca to develop the vaccine as part of fighting the Coronavirus outbreak.
The second phase of the vaccine studies have passed the scientists, the second phase of the vaccine protection will be tested in about 10 thousand participants, he said. The people to be tested will be made up of individuals between the ages of 5 and 69.
Prof. Dr. Andrew Pollard said the work was progressing successfully and will see if it provides protection in large-scale practice in the second phase.
A statement from the pharmaceutical company said that if the tests were successful, 400 million doses could be produced from the vaccine produced in the first place.